MRMD - MariMed Inc.
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 0.4100 |
| Open | 0.4117 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.4000 - 0.4375 |
| 52 Week Range | 0.2800 - 0.7700 |
| Volume | |
| Avg. Volume | 265,965 |
| Market Cap | 148.498M |
| Beta (5Y Monthly) | 3.02 |
| PE Ratio (TTM) | 13.67 |
| EPS (TTM) | 0.0300 |
| Earnings Date | Aug 07, 2023 - Aug 11, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.00 |
Fair Value
Related Research
GlobeNewswireMariMed Reports First Quarter 2023 Earnings
NORWOOD, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2023. “I am pleased to report another solid quarter,” said Jon Levine, Chief Executive Officer. “We reported our 13th consecutive quarter of positive adjusted EBITDA, and we expect to generate our fourth consecutive year of posi
InvestorPlace7 Best Penny Stocks Under $1 to Buy in May 2023
According to Finviz, there are 623 penny stocks under $1 to buy that trade on the New York Stock Exchange, the Nasdaq exchange, or the NYSE American exchange. However, while there are some promising plays among these 623 stocks, investors looking for cheap penny stocks under $1 may want to consider casting a wider net, and include stocks trading on the over-the-counter (or OTC) market in their search. There are over 4,000 stocks under $1 per share that trade over-the-counter, according to OTCMar
InvestorPlace7 of the Best Penny Stocks Under $3 to Buy Right Now
When it comes to finding the best penny stocks under $3 to buy now, there are scores of potential candidates. According to Finviz, there are nearly 1,500 publicly-traded companies listed on major U.S. exchanges that trade for $3 per share or less. Add in the similarly-sized number of sub-$3 per share stocks trading in the over-the-counter (OTC) markets, and it’s clear that investors targeting this risky yet high-potential end of the market have a wide pool of investment choices. That said, the v
- GlobeNewswire
MariMed Announces Opening of Panacea Wellness Dispensary in Beverly, Massachusetts
NORWOOD, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it opened an adult-use only Panacea Wellness Dispensary in Beverly, Massachusetts, marking the Company’s third operational dispensary in the state and the tenth dispensary that MariMed owns or manages across four states. The dispensary is located at 13 Enon Street in Beverly, a densely
- GlobeNewswire
MariMed Expands Board With the Addition of Kathleen Tucker
NORWOOD, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator (“MSO”), today announced that Kathleen Tucker has been appointed to the Company’s Board of Directors. Ms. Tucker has more than 25 years of senior executive experience in consumer marketing, product development, operations, finance, and technology with both iconic U.S. brands and cannabis companies. Since 2016, she has served as the Chief
InvestorPlaceThe 7 Best Cannabis Stocks to Buy for April 2023
Investors looking for the best cannabis stocks may be curious whether any of the more high-profile names are buying opportunities. After all, since the sector fell out of favor, once-popular plays like Canopy Growth (NASDAQ:CGC) and SNDL (NASDAQ:SNDL) have fallen to rock-bottom prices. But after some digging, I found some that could see higher highs. In fact, these companies, most of which are profitable on at least an EBITDA basis, may have the ability to move higher, thanks to numerous company
- GlobeNewswire
MariMed Announces First Quarter 2023 Earnings Date
NORWOOD, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its first quarter 2023 financial results on May 8, 2023 after the markets close. Management will host a conference call on May 9, 2023 at 8:00 a.m. EST to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations websit
- GlobeNewswire
MariMed Receives Approval to Once Again Produce and Sell High-Dosage Edibles in Maryland
NORWOOD, Mass., April 04, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced that its wholly owned subsidiary, Kind Therapeutics USA, has received approval from the Maryland Medical Cannabis Commission (“MMCC”) to immediately begin producing and distributing higher-dosage, THC-infused edibles. Maryland cannabis regulations changed in 2021, imposing a THC limit of 10 milligrams per edible serving
- GlobeNewswire
MariMed to Participate in Upcoming Investor Conferences
NORWOOD, Mass., April 03, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announced its participation in the following upcoming investor conferences: Benzinga Cannabis Capital Conference: CEO Jon Levine will participate in a panel discussion about "Nurturing New Growth: Exclusive Insights into Where Growth Will Occur in 2023," which will be moderated by Sally Kent Peebles
- GlobeNewswire
MariMed Announces Close on Acquisition of Ermont, Inc. Operating Assets
NORWOOD, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, and Ermont Inc. (“Ermont”) a vertically integrated medical cannabis operator located in Quincy, MA, today announced the close of MariMed’s transaction to acquire the operating assets of Ermont. The deal was previously announced on February 21, 2023. The acquisition marks the second medical dispensary for MariMed in Massachusetts, substa
Insider MonkeyMariMed Inc. (PNK:MRMD) Q4 2022 Earnings Call Transcript
MariMed Inc. (PNK:MRMD) Q4 2022 Earnings Call Transcript March 2, 2023 Operator: Good morning. My name is Michelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the MariMed Inc. Fourth Quarter 2022 Financial Results Conference Call. All lines have been placed on mute to prevent […]
Insider Monkey11 Most Profitable Pot Stocks Now
In this article, we will discuss the 11 most profitable pot stocks now. If you want to see more companies in this selection, go to the 5 Most Profitable Pot Stocks Now. Pot, or more formally known as cannabis or marijuana, is gaining widespread recognition as 46 states in the US have given either a […]
- GlobeNewswire
MariMed Reports Fourth Quarter and Full Year 2022 Financial Results
NORWOOD, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the fourth quarter and full year ended December 31, 2022. “I am pleased to report that our fourth quarter revenue grew sequentially and year-over-year as we continued to outperform the industry in all of our key states,” said Jon Levine, Chief Executive Office
- GlobeNewswire
MariMed Board of Directors Appoints Edward Gildea as Chairman and Jon Levine as Chief Executive Officer
NORWOOD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator (“MSO”), today announced its Board of Directors (the “Board”) has appointed Edward Gildea as Chairman of the Board and Jon Levine as Chief Executive Officer. Mr. Gildea has served as an independent director of the Company since 2013. Mr. Levine, co-founder and President of MariMed, has served as Interim CEO since the December passing of
- GlobeNewswire
MariMed To Expand Footprint in Massachusetts With Dispensary Acquisition in Quincy
NORWOOD, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its intention to acquire the operating assets of Ermont, Inc. (“Ermont”), a medical licensed vertical cannabis operator, located in Quincy, MA. Ermont who is presently in receivership with a court appointed receiver Opus Consulting Partners LLC. Opus and MariMed negotiated this transac
- GlobeNewswire
MariMed Announces Fourth Quarter 2022 Earnings Date
NORWOOD, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its fourth quarter 2022 financial results on March 1, 2023 after the markets close. Management will host a conference call on March 2, 2023 at 8:00 a.m. EST to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations we
- GlobeNewswire
MariMed Closes $35 Million Credit Facility to Accelerate its Strategic Growth Plans
NORWOOD, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announced that today it closed a $35 million secured credit facility with Chicago Atlantic Advisors, LLC (“Chicago Atlantic”) as the lead lender. “I am delighted to announce the closing of this transformative credit facility,” said Jon Levine, MariMed President and Interim Chief Executive Officer. “MariMed is known for its operational an
GlobeNewswireMariMed Strengthens Sales, Marketing, and R&D Teams With Senior Executive Hires
Matt Truppo MariMed Vice President of Retail, Matt Truppo Jay O'Malley MariMed Vice President of Marketing and Research & Development, Jay O'Malley Matt Truppo to Join as Vice President of Retail SalesJay O’Malley to Join as Vice President of Marketing and Research & Development NORWOOD, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced that two highly accomplished executives ha
Insider MonkeyMariMed Inc. (OTC:MRMD) Q3 2022 Earnings Call Transcript
MariMed Inc. (OTC:MRMD) Q3 2022 Earnings Call Transcript November 8, 2022 MariMed Inc. reports earnings inline with expectations. Reported EPS is $0.01 EPS, expectations were $0.01. Operator: Good morning. My name is Pam, and I will be your conference operator today. At this time, I would like to welcome everyone to the MariMed Third Quarter […]
- GlobeNewswire
MariMed Adds Candy Cane Flavored Vape Pen To Its InHouse Brand Line-up for the Holiday Season
NORWOOD, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) -- The Holiday Season just got merrier with the addition of a Candy Cane flavored disposable vape pen to the InHouse brand line-up of vapes and gummies launched by MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD) earlier this year. The limited edition InHouse Candy Cane disposable vape pen is available at select cannabis dispensaries in Massachusetts and Maryland, including MariMed’s Panacea Wellness locations in both states. The
- GlobeNewswire
MariMed Appoints Jon Levine as Interim Chief Executive Officer
NORWOOD, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its Board of Directors (the “Board”) appointed Jon Levine, MariMed’s President, as Interim Chief Executive Officer. “With a heavy heart on the news of Robert Fireman’s passing, appointing Jon Levine as Interim Chief Executive Officer was an easy decision,” said Edward Gildea, one of Ma
- GlobeNewswire
MariMed Mourns the Passing of Robert Fireman, Chairman, CEO And Cannabis Industry Pioneer and Visionary
NORWOOD, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced with deep sadness that Chairman, Chief Executive Officer, and co-founder Robert Fireman died unexpectedly on December 11, 2022. The Company will provide further information on succession once the Board has had an opportunity to determine the best path forward. "Bob Fireman worked tirel
InvestorPlace7 Marijuana Penny Stocks to Take Seriously in 2023
The marijuana sector has witnessed tremendous growth in recent years. In fact, newfound support has allowed cannabis companies to gain access to capital, which has helped fuel further growth. Additionally, as more and more states legalize cannabis, the market will only get bigger. One way to capitalize on the sector is by investing in marijuana penny stocks, which allows investors to gain exposure to this rapidly growing industry without putting up a lot of capital. With all of this positive mom
- GlobeNewswire
MariMed Announces Participation In Upcoming Conferences
NORWOOD, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its participation in the following upcoming conferences: Wolfe Research Virtual Consumer Conference: Senior management will participate in a panel moderated by Wolfe Research Retail Analyst, Greg Badishkanian on December 5th. Company management will also host one-on-one institutional i
- GlobeNewswire
MariMed Supports Giving At Thanksgiving
NORWOOD, Mass., Nov. 16, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, wants people to focus on enjoying the Thanksgiving Holiday and not on the cost of their turkey. That is why the Company for the second consecutive year is donating free turkeys to worthy community organizations, as part of in-store giveaways for customers and patients at its dispensaries, and to all C